These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3129897)

  • 1. Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.
    Minárovits J; Karczag E; Földes I
    Acta Microbiol Hung; 1987; 34(3-4):197-205. PubMed ID: 3129897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse peritoneal cells activated with a combination of indomethacin, poly I:C and Syncumar inhibit the take of Lewis lung carcinoma in adoptive transfer assay.
    Karczag E; Minárovits J; Földes I
    Acta Microbiol Hung; 1987; 34(3-4):207-14. PubMed ID: 3448880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of activated peritoneal cells inhibiting the take of transplantable murine tumours.
    Minárovits J; Karczag E; Földes I
    Acta Microbiol Hung; 1989; 36(1):33-9. PubMed ID: 2603645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of peritoneal and spleen cells of syngeneic or allogeneic origin on the take of transplantable murine tumours.
    Karczag E; Minárovits J; Földes I
    Acta Microbiol Hung; 1989; 36(1):25-31. PubMed ID: 2603643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
    Segawa K; Ueno Y; Kataoka T
    Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced take of spontaneous murine tumors in mice treated with inhibitors of macrophage and/or NK cell function.
    Minarovits J; Karczag E; Földes I
    Neoplasma; 1989; 36(1):3-9. PubMed ID: 2704423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents.
    Wiltrout RH; Brunda MJ; Gorelik E; Peterson ES; Dunn JJ; Leonhardt J; Varesio L; Reynolds CW; Holden HT
    J Reticuloendothel Soc; 1983 Sep; 34(3):253-69. PubMed ID: 6620256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
    Reidarson TH; Levy WE; Klostergaard J; Granger GA
    J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peritoneal cells on tumors cells growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage processing of antigen for induction of tumor immunity.
    Brunda MJ; Raffel S
    Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-inducibility is diminished in tumour-bearing mice.
    Hung PL; Stöger I; Karczag E; Minárovics J; Földes I
    Acta Microbiol Hung; 1989; 36(4):433-8. PubMed ID: 2484273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
    Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of some properties of normal or stimulated murine peritoneal macrophages.
    Fornůsek L; Vĕtvicka V
    Folia Biol (Praha); 1984; 30(1):67-79. PubMed ID: 6714482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
    J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface changes in mouse peritoneal macrophages after induction with proteose peptone or thioglycollate.
    Vĕtvicka V; Viklický V; Zelený V
    Folia Biol (Praha); 1979; 25(3):156-68. PubMed ID: 114430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.